Company profile: Sorrento Therapeutics
1.1 - Company Overview
Company description
- Provider of proprietary drug therapeutics under development to address unmet medical needs.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Sorrento Therapeutics
Cytognos
HQ: Spain
Website
- Description: Provider of flow cytometry solutions for blood cancer diagnosis, minimal residual disease detection, and immune monitoring research. Offers Infinicyt software for multicolor data integration and analysis; EuroFlow 8-color antibody panels; OC515 dye; APC-C750 fluorochrome; and Next Generation Flow immunophenotyping protocols.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cytognos company profile →
Bio-Convert
HQ: Denmark
Website
- Description: Provider of clinical-stage biopharmaceutical research and development focused on discovering and developing effective treatments for oral leukoplakia.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bio-Convert company profile →
Xstrahl
HQ: United States
Website
- Description: Provider of superficial orthovoltage X-ray systems for treating skin and bone cancers, dermatological disorders, benign conditions, and for palliative care, with precise non-surgical options. Also offers a compact office-based dual-modality device for non-melanoma skin cancers and keloid scarring, and advanced X-ray platforms for preclinical radiation biology research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Xstrahl company profile →
Atara Biotherapeutics
HQ: United States
Website
- Description: Provider of off-the-shelf, allogeneic T-cell immunotherapies, conducting clinical studies to evaluate safety and efficacy; offering expanded access to investigational drugs for treatment use; providing educational grants in T-cell immunotherapy; and supplying healthcare providers with information on products and clinical application.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Atara Biotherapeutics company profile →
Synta Pharmaceuticals
HQ: United States
Website
- Description: Provider of small molecule therapeutics to treat cancer and chronic inflammatory diseases, focused on the development and commercialization of these drugs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Synta Pharmaceuticals company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Sorrento Therapeutics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Sorrento Therapeutics
2.2 - Growth funds investing in similar companies to Sorrento Therapeutics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Sorrento Therapeutics
4.2 - Public trading comparable groups for Sorrento Therapeutics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →